More than Half of the U.S. House Asks Azar to Address Drug Makers’ 340B Actions Immediately
More than half of the U.S. House today told U.S. Health and Human Services (HHS) Secretary Alex Azar “it is imperative that immediate action is taken to ensure covered entities continue to receive crucial 340B drug discounts.”
The bipartisan Sept. 14 letter was spearheaded by Reps. David McKinley (R-W.Va), Diana DeGette (D-Colo.), Greg Gianforte (R-Mont.), Peter Welch (D-Vt.), Dusty Johnson (R-S.D.), and Doris Matsui (D-Calif.) 340B Report will provide the tally of signers by party affiliation tomorrow.
×